Biomarker Research Services Market by Service Type (Biomarker Research Services, and CDx Research Services), By Disease Indication (Oncology, Cardiovascular Disorder, Infectious Disease, Neurological Disorder, Immunological Disorder, and Others), By End User (Hospitals, Specialty Clinics, and Diagnostic Centers) and By Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

  • Published On : May 2019 |
  • Pages : 178 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Biomarker Research Services Market – Insights

Biomarkers are increasingly being used in all areas of medicine to help predict and characterize disease. The increasing focus on biomarkers is expected to significantly drive demand for biomarkers research services in development and validation of new biomarkers. Biomarker research services are provided by various contract research organizations for discovery, development, validation, and testing of biomarkers. Different companies provide different types of research services to their clients, however, most common types of services include discovery of a candidate biomarker, qualification, verification, research assay optimization, biomarker validation, and commercialization. Research institutes, pharmaceutical organizations, and biotechnology companies partner and collaborate with biomarker research service providers for development, validation, and commercialization of biomarkers, as well as companion diagnostics. Companion diagnostic is a diagnostic test used with a therapeutic drug to determine the drug’s applicability in a specific person. Companion diagnostics are developed based on companion biomarkers, biomarkers that prospectively help predict response, or severe toxicity of a therapeutic drug.

Increasing diagnostic applications of biomarkers is expected to boost global biomarker research services market growth over the forecast period

The use of biomarkers for diagnostics is increasing due to certain features of biomarkers, which include rapid detection of specific diseases. Biomarkers are used in a wide variety of neurological diseases, metabolic disorders, immune deregulation, and oncology. These help with detection of diseases such as, cancer and Alzheimer’s. Biomarkers are further used to detect Hemolytic disease of the newborn, Huntington disease, hereditary Hemochromatosis, and cystic fibrosis. In February 2018, U.S. Food and Drug Administration (FDA) granted marketing authorization to Banyan Biomarkers, Inc. for the first diagnostic blood test for traumatic brain injury, named Banyan BTI. Such innovations that target different indications are expected to increase demand for biomarkers. Therefore, increasing use of biomarkers in diagnosis of various diseases is expected to propel global biomarker research services market growth. Moreover, pharmaceuticals as well as biotechnology organizations are still lacking biomarker research capability for which they will need to employ services of contract research organizations.

The global biomarker research services market size was valued at US$ 5,897.7 million in 2017, and is expected to witness a robust CAGR of 13.5% over the forecast period (2018–2026).

Figure 1. Global Biomarker Research Services Market Share (%), by Region

     Biomarker Research Services  | Coherent Market Insights

   Source: Coherent Market Insights Analysis (2017)

High prevalence of chronic diseases is expected to boost growth of the global biomarker research services market over the forecast period

High prevalence of diseases such as cancer, cardiovascular diseases, and neurological diseases is expected to increase demand of biomarkers for diagnosis and treatment of these diseases. This, in turn, is expected to lead to high demand for biomarker research services, thereby boosting the market growth over the forecast period. For instance, according to World Health Organization (WHO), in February 2018, cancer was the second-leading cause of death worldwide, accounting for 8.8 million deaths. According to the data published by American Heart Association, in 2018, cardiovascular diseases, listed as the underlying cause of death, accounted for around 836,546 deaths in the U.S. which is around 1 in every 3 deaths in the U.S. Moreover, around 2,300 deaths are registered in the U.S due to cardiovascular diseases each day, with an average of 1 death in every 38 seconds. Furthermore, increasing application and approval of companion diagnostics is expected to spur manufacturers to invest in research and development of companion diagnostics. For instance, in April 2019, Qiagen N.V. announced the U.S. launch of the therascreen FGFR RGQ RT-PCR Kit (therascreen FGFR Kit) as a companion diagnostic to help guide the use of the newly approved FGFR kinase inhibitor, BALVERSA (erdafitinib), developed by Janssen Biotech, Inc. (Janssen).

Figure 2. Global Biomarker Research Services Market Share (%) by Service Type

        Biomarker Research Services  | Coherent Market Insights

However, development of biomarkers requires high investments due to cumbersome biomarker validation and testing processes. This, in turn, is expected to hamper global biomarker research services market growth.

Some major players operating in the global biomarker research services market include Noble Life Sciences, Inc., Reprocell Corporation, Coriell Institute, BioIVT, ICON Plc., SRI International, Inc., Charles River Laboratories, Inc., Nordic Bioscience A/S, Proteome Sciences Plc., and Covance Inc. (Laboratory Corporation of America Holdings, Inc.)

Biomarkers are widely used in development of drugs. One of the primary processes through which biomarkers are accepted for use in drug development, is the drug approval process. The biomarker is included in the regulatory submission process for drug approval such as Investigational New Drug (IND), Biologics License Disease Indications (BLA), or New Drug Disease Indication (NDA), and are then accepted for use in that specific drug development program. Another process through which biomarkers are accepted for use in drug development is the Biomarker Qualification Program (BQP), which qualifies a biomarker for a particular context of use (COU), independent of a drug approval submission. This pathway is intended for biomarkers that are used in multiple drug development programs. Qualified biomarkers have the potential to offer valuable information that may help during drug development.

Market Dynamics

Factors such as increasing initiatives for development of precision medicine, increasing prevalence of chronic diseases, and increasing demand for development of companion diagnostics, is supporting the growth of global biomarker research services market. For instance, in 2017, National Institutes of Health launched Precision Medicine Initiative (PMI) with an investment of US$ 215 million to accelerate biomedical research and offer clinicians new tools to select therapies that can be used in a more individualized approach with patients. Moreover, potential of biomarkers in disease diagnosis, and in companion diagnostics is expected to boost global biomarker research services market growth. Organizations such as Covance, Inc., Charles River, and others are actively involved in providing biomarker research services.

Key features of the study:

  • This report provides in-depth analysis of global biomarker research services market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights into market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global biomarker research services market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Noble Life Sciences, Inc., Reprocell Corporation, Coriell Institute, BioIVT, ICON Plc., SRI International, Inc., Charles River Laboratories, Inc., Nordic Bioscience A/S, Proteome Sciences Plc., and Covance Inc. (Laboratory Corporation of America Holdings, Inc.)
  • Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global biomarker research services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global biomarker research services market

Detailed Segmentation:

  • Global Biomarker Research Services Market, By Service Type:
    • Biomarker Research Services
    • CDx Research Services
  • Global Biomarker Research Services Market, By Disease Indication:
    • Oncology
    • Cardiovascular Disorder
    • Infectious Disease
    • Neurological Disorder
    • Immunological Disorder
    • Others
  • Global Biomarker Research Services Market, By Region:
    • North America
      • By Service Type:
        • Biomarker Research Services
        • CDx Research Services
      • By Disease Indication:
        • Oncology
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Service Type:
        • Biomarker Research Services
        • CDx Research Services
      • By Disease Indication:
        • Oncology
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Service Type:
        • Biomarker Research Services
        • CDx Research Services
      • By Disease Indication:
        • Oncology
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others          
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Service Type:
        • Biomarker Research Services
        • CDx Research Services
      • By Disease Indication:
        • Oncology
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others          
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • By Service Type:
        • Biomarker Research Services
        • CDx Research Services
      • By Disease Indication:
        • Oncology
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others          
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Service Type:
        • Biomarker Research Services
        • CDx Research Services
      • By Disease Indication:
        • Oncology
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others          
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Noble Life Sciences, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • REPROCELL Corporation
    • Coriell Institute
    • BioIVT
    • ICON Plc.
    • SRI International
    • Charles River Laboratories, Inc.
    • Nordic Bioscience A/S
    • Proteome Sciences Plc.
    • Covance Inc. (Laboratory Corporation of America Holdings, Inc.)

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Service Type
      • Market Snippet, By Disease Indication
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Qualified Biomarkers By U.S. FDA
    • Regulatory Scenario
    • U.S. FDA Biomarker Qualification Program
    • Key Highlights
    • Research and Development Collaboration, Mergers, and Acquisitions
    • PEST Analysis
    • Biomarker Development and Testing Technologies
    • Biomarker Development Pipeline
    • Epidemiology
  4. Global Biomarker Research Services Market, By Service Type, 2016–2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2018–2026
      • Segment Trends
    • Biomarker Research Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
    • Companion Diagnostics (CDx) Research Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
  5. Global Biomarker Research Services Market, By Disease Indication, 2016–2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2018–2026
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
    • Cardiovascular Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
    • Neurological Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
    • Immunological Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
  6. Global Biomarker Research Services Market, By Regions, 2016–2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018–2026
    • North America
      • Market Size and Forecast, By Service Type, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Service Type, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Service Type, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Service Type, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Service Type, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Service Type, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Noble Life Sciences, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • REPROCELL Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Coriell Institute
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • BioIVT
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • ICON Plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • SRI International
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Charles River Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Nordic Bioscience A/S
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Proteome Sciences Plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Covance Inc. (Laboratory Corporation of America Holdings, Inc.)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 26 market data tables and 32 figures on "Biomarker Research Services Market - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.